COVID-19: Concerns over increased load of residual antibiotics in wastewater

  02 September 2020

The use of antibiotics during the novel coronavirus disease (COVID-19) and its linkages with antimicrobial resistance (AMR) have earlier been talked about. Antibiotics are being employed — mostly in hospital or intensive care unit settings — to prevent secondary bacterial infections (co-infections) along with the viral infection caused by the SARS-CoV-2 virus that causes COVID-19.

Studies showed while the prevalence of bacterial infections was low in COVID-19 patients, a majority of them were administered with antibiotics, including broad spectrum ones. This was often done as part of empiric therapy, in the absence of appropriate bacterial characterisation or antibiotic susceptibility testing.

In parallel, there were emerging concerns over implications of such high levels of antibiotic use on the environment.

Further reading: DownToEarth
Author(s): Rajeshwari Sinha
Clean Environment  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

LifeArc

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Ambassador Network

Join the AMR Insights Ambassador Network today!

Connect to over 650 AMR professionals and students in 65 countries!

Register

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed